PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASE
Clinical trials for PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug slow lung scarring? new trial tests anlotinib for IPF
Disease control OngoingThis Phase 2 trial tests whether anlotinib, a drug currently used for cancer, can help people with idiopathic pulmonary fibrosis (IPF) or progressive fibrosis-interstitial lung disease. The study involves 30 adults aged 40-85 and measures changes in lung function over 52 weeks. P…
Matched conditions: PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Lung stem cell infusion shows promise in early IPF trial
Disease control OngoingThis early-stage study tests whether a person's own lung stem cells, grown from a small biopsy and given through an IV, are safe for treating idiopathic pulmonary fibrosis (IPF). Twenty-four adults with IPF will receive either a low or high dose of stem cells or standard care. Th…
Matched conditions: PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASE
Phase: PHASE1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC